Medicared For All Logo

Avinash Vyas in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Avinash Vyas has Internal Medicine as his primary medical specialty. Their primary office is: 608 Nw 9th St in Oklahoma City, Oklahoma.

They're a part of the: Saint Medical Group, Llc medical group which has around 302 members. You can call their office at 405-231-3000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1968 (around 56 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Avinash Chandra Vyas Office Phone and Directions

Avinash Vyas
Saint Medical Group, Llc
608 Nw 9th St
Oklahoma City, Oklahoma 73102
405-231-3000

Patient Ratings
Please rate your experience with Avinash Vyas below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 405-231-3000


Enter a starting address:


Healthcare Info for Avinash Vyas

Medical School: Sorry, his university is not listed
Graduation Year: 1968
The Primary Medical Specialty for Avinash Vyas is listed as: Internal Medicine
Approximate Years of Experience: 56
PAC (PECOS ID)#: 2961404355
NPI #: 1902878739
NPI Created On: 02/06/2006
NPI Last Updated Listed as: 10/19/2020
Primary Taxonomy Code: 207R00000X
License Number:
11243
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Hindi, Indian, VIETNAMESE, SPANISH, HINDI, SIGN LANGUAGE, ENGLISH.

Services and Procedures include:

  1. Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope
  2. Biopsy of large bowel using an endoscope
  3. Removal of polyps or growths of large bowel using an endoscope
  4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Hospital observation care on day of discharge
  9. Hospital observation care, typically 50 minutes
  10. Initial hospital inpatient care, typically 50 minutes per day
  11. Initial hospital inpatient care, typically 70 minutes per day
  12. Subsequent observation care, typically 25 minutes per day
  13. Subsequent hospital inpatient care, typically 25 minutes per day
  14. Subsequent hospital inpatient care, typically 35 minutes per day
  15. Hospital discharge day management, 30 minutes or less
  16. Hospital discharge day management, more than 30 minutes
  17. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
  18. Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
  19. Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp
  20. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796214039

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VIIBRYD

Open Associated Drug #1: 0456-1140-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796214041

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783531401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $72

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805264797

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GI COLON PREP

Name of Drug #1: SUTAB

Open Associated Drug #1: 52268-201-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 815664725

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Continuous Glucose Monitoring

Name of Drug #1: Guardian Connect

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 820322641

Being Disputed:: No

Product Related: No

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835342601

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835342603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835342605

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 835342607

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: SICKLE CELL DISEASE

Name of Drug #1: OXBRYTA

Open Associated Drug #1: 72786-101-01

Internal Medicine Professionals in Oklahoma City

1.
Rhevanth Kasinchetty

1000 N Lee Ave
Oklahoma-city, OK
Metro Physicians Llc

2.
Rhevanth Kasinchetty

1111 N Lee Ave
Oklahoma-city, OK
Metro Physicians Llc

3.
Rhevanth Kasinchetty

1000 N Lee Ave
Oklahoma-city, OK
Hospitalist Medicine Physicians Of Texas Pllc

4.
Mark Allee MD

1000 Ne 13th St
Oklahoma-city, OK
Ou Health Partners Inc

5.
Mark Allee MD

900 Ne 10th St
Oklahoma-city, OK
Ou Health Partners Inc

6.
Srikanth Nallacheru

900 Ne 10th St
Oklahoma-city, OK
Ou Health Partners Inc

Providers in Saint Medical Group, Llc

1.Robert Abell Md

1110 N Lee Ave
Oklahoma City Ok 73103-2612
Saint Medical Group, Llc
Family Practice

2.Robert Abell Md

608 Nw 9th St
Oklahoma City Ok 73102-1049
Saint Medical Group, Llc
Family Practice

3.Ernest Abunaw

608 Nw 9th St
Oklahoma City Ok 73102-1068
Saint Medical Group, Llc
Psychiatry

4.Carson Agee Md

535 Nw
Okahoma City Ok 73102-1070
Saint Medical Group, Llc
General Surgery

5.Hala Akkary

608 Nw 9th St
Oklahoma City Ok 73102-1049
Saint Medical Group, Llc
Physician Assistant

6.Tauseef Ali

608 Nw 9th St
Oklahoma City Ok 73102-1068
Saint Medical Group, Llc
Gastroenterology

View all 302 members of Saint Medical Group, Llc medical group


Medicared For All
Vote!
Share